Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors-Reference-Cited by-同舟云学术

Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors

Published:2020-01 Issue: Volume:469 Page:323-331
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Petrara Maria Raffaella,Serraino Diego,Di Bella Caterina,Neri Flavia,Del Bianco Paola^ORCID,Brutti Martina,Carmona Francesco,Ballin Giovanni,Zanini Stefano,Rigotti Paolo,Furian Lucrezia,De Rossi Anita^ORCID

Funder

Associazione Italiana per la Ricerca sul Cancro

Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padova, Italy

AIRC

DiSCOG

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States;Quinlan;Am. J. Hematol.,2011

2. Incidence of post-transplantation lymphoproliferative disease in Andalusia (1990-2009);Govantes;Transplant. Proc.,2013

3. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study;Francis;Nephrol. Dial. Transplant.,2018

4. Clinical characteristics and outcomes of PTLD following intestinal transplantation;Wozniak;Clin. Transplant.,2018

5. Posttransplant lymphoproliferative disorder in adults receiving kidney transplantation in British Columbia: a retrospective cohort analysis;Ready;Can. J. Kidney Health Dis.,2018

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BCR signaling is required for posttransplant lymphoproliferative disease in immunodeficient mice receiving human B cells;Science Translational Medicine;2024-04-10

2. Impact of Immunosenescence in Older Kidney Transplant Recipients: Associated Clinical Outcomes and Possible Risk Stratification for Immunosuppression Reduction;Drugs & Aging;2024-02-22

3. Association of T Cell Subsets and Platelet/Lymphocyte Ratio with Long-Term Complications in Kidney Transplant Recipients;Medical Science Monitor;2024-02-05

4. Early Proteomic and Innate Immunity Profiles: A Footprint of Increased Mortality Risk In Infants Living with Hiv From Three African Countries;2024

5. The case for the therapeutic use of mechanistic/mammalian target of rapamycin (mTOR) inhibitors in xenotransplantation;Xenotransplantation;2023-04-07